荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09995 荣昌生物

未开盘 07-23 16:08:06

87.300

+1.500

+1.75%

最高88.600	最低85.150	成交量213.06万
今开86.650	昨收85.800	日振幅4.02%
总市值492.03亿	流通市值182.09亿	总股本5.64亿
成交额1.86亿	换手率1.02%	流通股本2.09亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"荣昌生物","latestPrice":87.3,"timestamp":1784794086010,"preClose":85.8,"halted":0,"volume":2130582,"delay":0,"changeRate":0.017482517482517484,"floatShares":208581239,"shares":563608243,"eps":1.492427314640572,"marketStatus":"未开盘","change":1.5,"latestTime":"07-23 16:08:06","open":86.65,"high":88.6,"low":85.15,"amount":185696990,"amplitude":0.04021,"askPrice":87.3,"askSize":500,"bidPrice":87.1,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":2.7007126654591644,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784856600000},"marketStatusCode":0,"adr":0,"listingDate":1604851200000,"exchange":"SEHK","adjPreClose":85.8,"openAndCloseTimeList":[[1784770200000,1784779200000],[1784782800000,1784793600000]],"volumeRatio":0.424106,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"荣昌生物","latestPrice":124.59,"timestamp":1784790000000,"preClose":126.9,"halted":0,"volume":6304100,"delay":0,"premium":"-39.43"}},"requestUrl":"/m/hq/s/09995","defaultTab":"news","newsList":[{"id":"1131916151","title":"港股直击 | 创新药板块走高，康方生物涨近7%，康诺亚-B、荣昌生物涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131916151","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131916151?lang=zh_cn&edition=full","pubTime":"2026-07-23 13:46","pubTimestamp":1784785579,"startTime":"0","endTime":"0","summary":"7月23日，创新药板块走高，康方生物涨近7%，康诺亚-B、荣昌生物涨超3%，恒瑞医药、药明康德涨超2%，药明生物涨近2%。消息面上，康诺亚-B公告称，公司重点研发产品CM512（TSLP/IL-13双抗）已被国家药监局药审中心纳入突破性治疗品种名单，拟用于治疗慢性鼻窦炎伴鼻息肉。CM512为公司自主研发的IgG-like长效型TSLPxIL-13双阻断剂，此前I期临床研究已于2025年11月达成全部研究终点，并于2026年4月在《Journal of Translational Medicine》发表相关结果。目前，CM512用于慢性鼻窦炎伴鼻息肉的II期临床研究正在推进，公司同时布局中重度哮喘、中重度慢阻肺、成人中重度特应性皮炎、慢性自发性荨麻疹等多个适应症。","market":"hk","thumbnail":"https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162","09926","02269","02359","09995","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653756956","title":"荣昌生物（688331）披露2026年第一次回购股份事项前十名股东持股情况，7月22日股价下跌0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653756956","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653756956?lang=zh_cn&edition=full","pubTime":"2026-07-22 17:42","pubTimestamp":1784713342,"startTime":"0","endTime":"0","summary":"截至2026年7月22日收盘，荣昌生物报收于126.9元，较前一交易日下跌0.59%，最新总市值为716.32亿元。该股当日开盘127.6元，最高132.5元，最低126.01元，成交额达10.74亿元，换手率为2.34%。荣昌生物制药（烟台）股份有限公司于2026年7月19日召开第三届董事会第二次会议，审议通过了《关于2026年第一次以集中竞价交易方式回购公司股份方案的议案》。根据相关规定，公司于近日披露截至2026年7月17日公司A股前十名股东和前十名无限售条件股东的持股情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200036275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09995","BK1574","BK0239","LU1969619763.USD","LU2148510915.USD","LU2488822045.USD","BK1161","BK1583","688331","LU2328871848.SGD","LU1064131003.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145405224","title":"港股直击 | 生物医药股走强，康方生物涨近7%，荣昌生物涨超4%，泰格医药、诺诚健华涨近3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1145405224","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145405224?lang=zh_cn&edition=full","pubTime":"2026-07-22 10:11","pubTimestamp":1784686287,"startTime":"0","endTime":"0","summary":"7月22日，港股生物医药股走强，康方生物涨近7%，荣昌生物涨超4%，泰格医药、诺诚健华涨近3%，复宏汉霖、药明康德、君实生物涨超2%。消息面上，美国总统特朗普当地时间7月21日在社交媒体发文表示，自2026.8.1起，所有进口到美国的仿制药将在未来两年内继续适用零关税。两年期满后，相关产品将被征收100%的关税，期限为一年。此后，关税将进一步提高至200%。","market":"hk","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股直击 | 生物医药股走强，康方生物涨近7%，荣昌生物涨超4%，泰格医药、诺诚健华涨近3%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995","01877","02359","09969","09926","03347","02696"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179263578","title":"异动解读｜荣昌生物盘中上涨4.23%，A股回购方案即将落地叠加创新药板块持续走强","url":"https://stock-news.laohu8.com/highlight/detail?id=1179263578","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179263578?lang=zh_cn&edition=full","pubTime":"2026-07-22 09:48","pubTimestamp":1784684891,"startTime":"0","endTime":"0","summary":"7月22日，荣昌生物盘中上涨4.23%，报88.4港元，成交额8461.51万港元。消息面上，公司7月21日披露回购前夕股权结构，公布截至7月17日的A股前十大股东持股情况，为即将实施的首次集中竞价回购方案提供基准数据，标志回购进入实质操作阶段。此前公司董事会已于7月19日全票通过该方案，拟以不超过5000万元回购A股用于员工持股计划或股权激励。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115237610","title":"荣昌生物（09995）公布2026年首次回购前夕股权结构","url":"https://stock-news.laohu8.com/highlight/detail?id=1115237610","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115237610?lang=zh_cn&edition=full","pubTime":"2026-07-21 20:25","pubTimestamp":1784636740,"startTime":"0","endTime":"0","summary":"荣昌生物制药（烟台）股份有限公司7月22日在上海证券交易所网站披露，截至2026年7月17日的A股前十大股东及其持股情况，为公司即将实施的2026年第一次集中竞价回购股份方案提供基准数据。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652290964","title":"创新药火速修复，520880成反弹急先锋！场内唯一药ETF8天7涨！映恩生物、艾力斯、荣昌生物等多股释放利好","url":"https://stock-news.laohu8.com/highlight/detail?id=2652290964","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652290964?lang=zh_cn&edition=full","pubTime":"2026-07-20 19:19","pubTimestamp":1784546340,"startTime":"0","endTime":"0","summary":"周一，AH医药资产经历上周“黑色星期五”后率先迎来修复。港股通医药弹性十足，港股通创新药ETF华宝、港股通医疗ETF华宝大涨4.17%、3.27%。A股医药逆市活跃，药ETF华宝、医疗ETF华宝携手反弹2.5%。　　港股通创新药全天强势，100%创新药研发标的——520880盘中一度上探4.63%，放量成交8.1亿元。　　A股制药板块同步反弹，场内唯一跟踪制药指数的药ETF华宝低开后直线拉升翻红，盘中冲高3%，收涨2.58%走出“8天7涨”。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-07-20/doc-iniinfqe4980267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688578","09995","LU1969619763.USD","BK1583","MEDX","LU2488822045.USD","LU2148510915.USD","520880","IBBQ","159992","688331","LU2328871848.SGD","06978","BK1161","BK0239","LU1064130708.USD","BK1574","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652426701","title":"港股异动 | 荣昌生物(09995)涨超8% 拟最高5000万元回购A股 泰它西普商业化潜力有望释放","url":"https://stock-news.laohu8.com/highlight/detail?id=2652426701","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652426701?lang=zh_cn&edition=full","pubTime":"2026-07-20 14:21","pubTimestamp":1784528485,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，荣昌生物涨超8%，截至发稿，涨8.33%，报82.6港元，成交额3.72亿港元。消息面上，荣昌生物昨晚公布，以总金额不低于2500万元，不超过5000万元自有资金和/或自筹资金通过集中竞价交易方式回购A股。回购的股份拟用于员工持股计划或股权激励。值得一提的是， 今年6月，荣昌生物公告泰它西普新获批上市两项新适应症IgA 肾病和干燥综合征。浙商证券认为，此举将进一步释放泰它西普的商业化潜力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469657.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1969619763.USD","LU1064130708.USD","BK1583","159982","LU2148510915.USD","BK4585","LU2328871848.SGD","VXUS","BK1161","BK1574","LU1064131003.USD","BK0239","KCAI","LU2488822045.USD","BK4588","399300","09995","688331"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162098983","title":"港股直击 | 生物医药股板块走强，荣昌生物、药明合联、康诺亚涨近8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1162098983","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162098983?lang=zh_cn&edition=full","pubTime":"2026-07-20 11:22","pubTimestamp":1784517729,"startTime":"0","endTime":"0","summary":"7月20日，生物医药股板块走强，荣昌生物、药明合联、康诺亚涨近8%，君实生物涨近7%，康方生物涨近6%，药明生物涨近5%。消息面上，创新药板块近期迎来多重催化。一方面，政策端持续释放支持信号，国务院发布《国民健康“十五五”规划》，提出加强创新药和医疗器械全链条支持，优化创新药及临床急需药品审评审批机制，进一步完善创新药发展环境。另一方面，国产创新药商业化和海外授权进展持续受到关注，工信部数据显示，今年上半年共有38款创新药获批上市，其中国产创新药占比超过80%。随着下半年全球医学会议密集召开，包括WCLC、ESMO、ASH等重要学术会议，部分创新药企业核心管线的临床数据将陆续披露，市场关注重点重新回到研发进展和商业化兑现能力。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877","02513","02269","02162","09926","02268","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652269822","title":"创新药板块活跃 荣昌生物(09995)涨7.28% 多支头部公募大举举牌港股创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2652269822","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652269822?lang=zh_cn&edition=full","pubTime":"2026-07-20 10:26","pubTimestamp":1784514372,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药板块活跃，荣昌生物 涨7.28%，歌礼制药-B涨6.81%，科伦博泰生物涨6.70%，康诺亚-B涨6.25%，康方生物涨5.83%，药明合联涨5.53%，石药集团涨4.94%，三生制药涨5.02%，信达生物涨4.55%，药明生物涨4.60%，恒瑞医药涨4.00%，百济神州涨3.88%。头部机构密集触及举牌线，凸显对创新药板块的看好。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986240","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2399975544.HKD","LU0516422366.SGD","LU0348735423.USD","HK0000165453.HKD","LU0043850808.USD","06160","LU0359201612.USD","01093","LU0979878070.USD","LU2097828474.EUR","BK1593","IBBQ","LU0052750758.USD","09995","KURE","LU1226288170.HKD","LU0348827113.USD","LU0516422440.USD","LU0708995583.HKD","BK4585","06978","01530","01276","BK1576","LU0417516738.SGD","LU0516423174.USD","09926","MEDX","BK1588","LU1720050803.USD","02269","LU1951186391.HKD","SG9999002463.SGD","01672","BK0239","688331","IE00BZ08YT58.USD","LU0327786744.USD","LU2328871848.SGD","KCAI","VXUS","LU1064130708.USD","01801","02268","LU0196878994.USD","LU1242518857.USD","02162","159992","06990","LU1242518931.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128190151","title":"异动解读｜荣昌生物盘中上涨5.11%，公司公布首个A股回购计划提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1128190151","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128190151?lang=zh_cn&edition=full","pubTime":"2026-07-20 09:50","pubTimestamp":1784512248,"startTime":"0","endTime":"0","summary":"7月20日，荣昌生物盘中上涨5.11%，报81.45港元，成交额8144.51万港元。消息面上，公司于7月19日召开董事会审议通过首个A股回购方案，拟以集中竞价方式回购股份，资金上限5000万元，回购期限为董事会审议通过之日起12个月内。此外，公司核心产品泰它西普近期被纳入国家基本药物目录\"免疫系统用药\"类别，商业化前景进一步明朗。叠加创新药板块整体回暖，同行业信达生物涨4.1%、百济神州涨3.77%、康方生物涨3.74%，板块资金持续回流。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652252861","title":"赛力斯董事、高管及骨干团队累计增持255万股；协创数据预计上半年净利润同比增长247%~340% | 公告精选","url":"https://stock-news.laohu8.com/highlight/detail?id=2652252861","media":"每日经济新闻","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652252861?lang=zh_cn&edition=full","pubTime":"2026-07-19 22:30","pubTimestamp":1784471429,"startTime":"0","endTime":"0","summary":"业绩预告国际复材：预计2026年上半年净利润同比增长151%~194%国际复材公告称，预计2026年半年度归母净利润为5.80亿元~6.80亿元，同比增长151%~194%。报告期内，公司持续推进产品结构优化，产品量价实现双增长。其中，电子领域受下游产业需求增长的影响，电子级玻璃纤维及制品价格上涨，净利润同比大幅增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607193811866738.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607193811866738.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1781817850.SGD","600909","603980","688331","LU2399975544.HKD","300184","SGXZ49509284.SGD","300857","BK0229","LU1064130708.USD","BK0167","LU1794554557.SGD","LU2778985437.USD","601966","300627","LU1997245177.USD","LU2476274308.USD","BK0132","BK0014","BK0185","601127","BK0028","300776","BK0231","BK0148","LU1720050803.USD","300502","BK0109","BK0192","BK0239","LU2289578879.USD","603920","LU1997244956.HKD","LU2460026573.USD","LU2488822045.USD","BK0078","BK0276","BK0264","BK0201","BK0250","09995","BK0183","BK0251","LU1961090484.USD","LU1064131003.USD","SGXZ81163826.USD","BK0214","BK0012","BK0220","09927","LU1997245094.SGD","LU1580142542.USD","300682","LU2495084118.USD","BK0051","LU2148510915.USD","BK0196","LU2476274720.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136623446","title":"荣昌生物（09995）披露首份A股集中竞价回购预案：金额上限5,000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1136623446","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136623446?lang=zh_cn&edition=full","pubTime":"2026-07-19 19:11","pubTimestamp":1784459489,"startTime":"0","endTime":"0","summary":"7月20日，荣昌生物公告披露《2026年第一次以集中竞价交易方式回购公司股份的预案》。公司已于2026年7月19日召开第三届董事会第二次会议，9名董事一致同意通过该回购方案，无弃权及反对票。公司承诺在回购期间严格遵守相关法律法规，及时披露回购进展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167495913","title":"荣昌生物制药（09995）拟斥资最高5,000万元A股回购用于员工激励","url":"https://stock-news.laohu8.com/highlight/detail?id=1167495913","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167495913?lang=zh_cn&edition=full","pubTime":"2026-07-19 19:11","pubTimestamp":1784459481,"startTime":"0","endTime":"0","summary":"荣昌生物制药（烟台）股份有限公司7月20日公告披露，公司第三届董事会第二次会议已于2026年7月19日召开并通过《关于2026年第一次以集中竞价交易方式回购公司股份方案的议案》。本次回购资金总额不低于2,500万元人民币（含），不超过5,000万元人民币（含）。\\n\\n公司计划在未来适当时机将回购股份用于员工持股计划或股权激励。董事会授权公司管理层全权办理相关事宜。公司表示，本次回购旨在提升投资者信心，促进公司稳定、健康、可持续发展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135012631","title":"荣昌生物(09995)公布首个2026年A股回购计划：斥资最高5,000万元回购至多33.56万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1135012631","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135012631?lang=zh_cn&edition=full","pubTime":"2026-07-19 19:11","pubTimestamp":1784459473,"startTime":"0","endTime":"0","summary":"2026年7月20日，荣昌生物制药（烟台）股份有限公司在上海证券交易所网站披露《2026年第一次以集中竞价交易方式回购公司股份的回购报告书》。公司已于2026年7月19日召开的第三届董事会第二次会议，以9票同意、0票反对、0票弃权审议通过本次回购方案，无需提交股东大会审议。回购股份将通过集中竞价交易方式实施，期限自董事会审议通过之日起12个月内。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652259934","title":"荣昌生物最新公告：拟以2500万元—5000万元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2652259934","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652259934?lang=zh_cn&edition=full","pubTime":"2026-07-19 16:50","pubTimestamp":1784451047,"startTime":"0","endTime":"0","summary":"荣昌生物(688331.SH)公告称，公司拟以2500万元—5000万元回购公司股份，用于员工持股计划或股权激励，回购价格不超过149元/股。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900007010.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0239","09995","BK1583","688331","LU1969619763.USD","LU1064130708.USD","LU2328871848.SGD","BK1161","LU2148510915.USD","LU2488822045.USD","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141080845","title":"异动解读｜荣昌生物盘中下跌5.06%，创新药板块集体走弱叠加解禁抛压延续","url":"https://stock-news.laohu8.com/highlight/detail?id=1141080845","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141080845?lang=zh_cn&edition=full","pubTime":"2026-07-17 10:01","pubTimestamp":1784253713,"startTime":"0","endTime":"0","summary":"7月17日，荣昌生物盘中下跌5.06%，报78.85港元，成交额1.17亿港元。同日生物科技板块集体承压，康方生物跌8.15%、三生制药跌7.15%、科伦博泰生物跌4.57%。消息面上，公司7月1日完成1.93亿股首发限售股解禁上市流通，占总股本34.16%，此后股价持续承压。7月9日至10日公司A股曾出现20CM跌停及连续大跌，3日跌幅偏离值累超30%，公司回应称股价走势超出预期，经营正常。实控人随即公告拟以1000万至2000万元增持，但市场情绪修复有限。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651341039","title":"创新药连续大涨，这次真的不一样了吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2651341039","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651341039?lang=zh_cn&edition=full","pubTime":"2026-07-16 17:05","pubTimestamp":1784192720,"startTime":"0","endTime":"0","summary":"政策上，医保初审通过率创新高，定价机制优化，并建立“医保+商保”双层支付体系；产业上，上半年BD交易总额达1100亿美元，国际竞争力显著提升；资金面上，内外资持续回流。行业正从“讲故事”转向盈利兑现，国金证券认为，2027年有望成为中国创新药海外商业化集中兑现的重要节点。","market":"hk","thumbnail":"https://static.tigerbbs.com/8daedf52c02cecfd417dcbd813afb3fa","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8daedf52c02cecfd417dcbd813afb3fa"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3777107","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","06606","09966","09995","00241","09688","BK1161","03759","159992","09606","03347","02269","06622","06618","MEDX","02268","IBBQ","01801","02359","06978","BK1574","02137","06996"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2651291435","title":"创新药概念全线扬升 科伦博泰生物(06990)涨逾11% 机构指创新药企迎业绩兑现窗口","url":"https://stock-news.laohu8.com/highlight/detail?id=2651291435","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651291435?lang=zh_cn&edition=full","pubTime":"2026-07-15 11:07","pubTimestamp":1784084836,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股创新药概念盘中全线扬升，截至发稿，欧康维视生物-B 涨13.35%，科伦博泰生物涨11.20%，康方生物涨8.82%，信达生物涨8.72%，三生制药涨8.11%，康诺亚-B涨7.62%，药明合联涨7.52%，荣昌生物涨7.09%，乐普生物涨6.87%，亚盛医药涨6.26%。该机构持续看好国内创新药出海β向上可持续性，提示投资者关注2027年起众多前期已达成BD的分子将在海外开启商业化新周期所带来的投资机会。","market":"fut","thumbnail":"https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985914","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516738.SGD","LU2399975544.HKD","BK1587","LU2778985437.USD","LU2476274308.USD","KURE","LU0417516902.SGD","BK1191","09995","09926","01477","IE00B543WZ88.USD","BK1583","LU0561508036.HKD","LU0417516571.SGD","01530","06855","02157","LU2097828805.USD","BK1574","BK1141","LU2097828557.USD","LU0455707207.USD","01801","IBBQ","BK1161","06990","06978","LU0634319403.HKD","MEDX","02162","LU0348784397.USD","BK1593","LU0348767384.USD","IE00BPRC5H50.USD","LU2097828631.EUR","159992","LU0540923850.HKD","LU0348825331.USD","BK1589","LU1961090484.USD","02268","LU0348827113.USD","SG9999014674.SGD","LU2097828714.EUR","LU2488822045.USD","LU2097828474.EUR","LU0502904849.HKD","LU2328871848.SGD","LU1720050803.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651787480","title":"【券商聚焦】交银国际：新版基药目录落地 荣昌、先声、康诺亚关键品种有望迎放量机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2651787480","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651787480?lang=zh_cn&edition=full","pubTime":"2026-07-15 09:14","pubTimestamp":1784078047,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际研报指，新版基药目录落地，重点聚焦创新药、慢病药和儿童药：本次新增116个品种均为现行医保目录内药品。据测算，新版基药目录药品占全国公立医疗卫生机构药品配备品种使用总量的71%，其中基层/二级/三级医疗机构占比分别为78%/74%/65%。","market":"us","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985881","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0880133367.SGD","LU1813983027.USD","BK1147","IE00B5MMRT66.SGD","SG9999004220.SGD","01093","LU0326950275.SGD","IE00B543WZ88.USD","LU0315179316.USD","LU1226287792.SGD","LU0314109678.HKD","LU1008478684.HKD","02096","LU1226287875.USD","LU0501845795.SGD","BK1515","LU0072913022.USD","KURE","LU1993786604.SGD","LU2039709279.SGD","03329","BK1587","09995","LU1152091168.USD","BK1574","BK1583","IE00BZ08YR35.GBP","02162","LU1152091754.HKD","LU0067412154.USD","BK1521","IE00BZ08YT58.USD","IE00BZ08YS42.EUR","LU1807302812.USD","IE0008368742.USD","BK1161","LU1328277881.USD","LU1226288170.HKD","BK1191","LU1226288253.USD","HK0000165453.HKD","LU0140636845.USD","IE0008369823.USD","LU1951186391.HKD","KCE","LU1960683339.HKD","LU1969619763.USD","LU2328871848.SGD","LU1226287529.USD","IE00B031HY20.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651991128","title":"【券商聚焦】中信证券：新基药目录有望加速创新药基层落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2651991128","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651991128?lang=zh_cn&edition=full","pubTime":"2026-07-14 08:57","pubTimestamp":1783990650,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信证券研究指，《2026年版国家基本药物目录》于7月9日正式发布，将于9月1日起实施。该机构认为，本次新版基药目录新增药物均已属于医保药品，随着基药与医保的深度协同联动，有望极大加速创新药的基层落地，医保控费与创新回报形成良性循环。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250106/ZGNkM2E3NDVjMTk0N2Q5ZDk4NjYxNjc1YjA4NjMzOTA5MjkwMDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZGNkM2E3NDVjMTk0N2Q5ZDk4NjYxNjc1YjA4NjMzOTA5MjkwMDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1985769","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2476274720.SGD","MEDX","LU0588546209.SGD","LU1960683339.HKD","LU0359201612.USD","02142","06030","KURE","BK1161","LU0405327494.USD","06978","LU0051755006.USD","BK1610","KCE","IBBQ","LU0314109678.HKD","LU0417516902.SGD","LU1242518931.SGD","IE00BPRC5H50.USD","LU0979878070.USD","LU1226287792.SGD","01093","LU1152091168.USD","06185","09926","BK1500","09688","159992","LU1997244956.HKD","02269","HK0000165453.HKD","LU0327786744.USD","LU0572944931.SGD","01877","LU1328277881.USD","LU0043850808.USD","IE0008368742.USD","01801","LU0823426480.USD","LU2488822045.USD","SG9999002463.SGD","09995","01177","LU2039709279.SGD","02616","LU1961090484.USD","LU1226288253.USD","LU2328871848.SGD","600030","06160"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0271},{"period":"1month","weight":0.3059},{"period":"3month","weight":-0.1622},{"period":"6month","weight":-0.0322},{"period":"1year","weight":0.3128},{"period":"ytd","weight":0.2125}],"compareEarnings":[{"period":"1week","weight":0.0081},{"period":"1month","weight":0.0803},{"period":"3month","weight":-0.0295},{"period":"6month","weight":-0.0575},{"period":"1year","weight":-0.0128},{"period":"ytd","weight":-0.0164}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"荣昌生物制药（烟台）股份有限公司是一家主要从事生物医药研究、生物医药服务及生物医药生产和销售的中国公司。该公司专注于抗体药物偶联物（ADC）、抗体融合蛋白、单抗及双抗等治疗性抗体药物领域。该公司的主要产品包括泰它西普、维迪西妥单抗、RC28-E等。该公司的产品主要应用于自身免疫疾病、肿瘤疾病、眼科疾病等重大疾病领域。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.110172},{"month":2,"riseRate":0.666667,"avgChangeRate":0.167223},{"month":3,"riseRate":0.5,"avgChangeRate":0.012545},{"month":4,"riseRate":0.833333,"avgChangeRate":0.095268},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.049233},{"month":6,"riseRate":0.666667,"avgChangeRate":0.089626},{"month":7,"riseRate":0.666667,"avgChangeRate":0.002228},{"month":8,"riseRate":0.4,"avgChangeRate":0.068611},{"month":9,"riseRate":0.6,"avgChangeRate":0.099222},{"month":10,"riseRate":0.4,"avgChangeRate":0.027845},{"month":11,"riseRate":1,"avgChangeRate":0.038747},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.053467}],"exchange":"SEHK","name":"荣昌生物","nameEN":"REMEGEN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荣昌生物,09995,荣昌生物股票,荣昌生物股票老虎,荣昌生物股票老虎国际,荣昌生物行情,荣昌生物股票行情,荣昌生物股价,荣昌生物股市,荣昌生物股票价格,荣昌生物股票交易,荣昌生物股票购买,荣昌生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荣昌生物(09995)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荣昌生物(09995)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}